The REVAMP trial: key questions remain

Affiliations

¹ Division of Transfusion Medicine and Cell Therapy, The Jikei University Hospital, Tokyo 1058471, Japan. Electronic address: tomosatou@jikei.ac.jp.
² Division of Blood Transfusion, Shinshu University Hospital, Nagano, Japan.

Comment

Tomohiko Sato et al. Lancet. 2024.

. 2024 Jan 6;403(10421):28-29.

doi: 10.1016/S0140-6736(23)01919-0.

¹ Division of Transfusion Medicine and Cell Therapy, The Jikei University Hospital, Tokyo 1058471, Japan. Electronic address: tomosatou@jikei.ac.jp.
² Division of Blood Transfusion, Shinshu University Hospital, Nagano, Japan.

No abstract available

Comment in

The REVAMP trial: key questions remain - Authors' reply.
Pasricha SR, Moya E, Ataide R, Mzembe G, Harding R, Phiri K. Pasricha SR, et al. Lancet. 2024 Jan 6;403(10421):29-30. doi: 10.1016/S0140-6736(23)01915-3. Lancet. 2024. PMID: 38184336 No abstract available.

Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial.
Pasricha SR, Mwangi MN, Moya E, Ataide R, Mzembe G, Harding R, Zinenani T, Larson LM, Demir AY, Nkhono W, Chinkhumba J, Simpson JA, Clucas D, Stones W, Braat S, Phiri KS. Pasricha SR, et al. Lancet. 2023 May 13;401(10388):1595-1609. doi: 10.1016/S0140-6736(23)00278-7. Epub 2023 Apr 21. Lancet. 2023. PMID: 37088092 Free PMC article. Clinical Trial.